Anthropic (ANT) is now available for trading at Exness, allowing CFD traders to take a view on its IPO in either direction without owning the underlying shares.
Anthropic has made its highly anticipated debut under the ticker ANT, opening a new chapter in the AI boom. However, the company’s public debut comes amid persistent inflation, political uncertainty, and growing concerns over AI infrastructure spending. With technology valuations under pressure, could Anthropic’s biggest trading opportunity turn into a flop?
At Exness, traders can take a position in either direction through ANT CFDs without owning the underlying shares. Those expecting further gains can go long, while those anticipating a disappointing market debut can go short.
Even before its listing, expectations around Anthropic’s valuation have been a roller coaster ride. Earlier discussions placed its potential IPO valuation at approximately $2 trillion, before expectations moved toward $1.5 trillion in October. Following the AI stock selloff, prospective buyers reportedly considered valuations of $1.2 trillion to $1.3 trillion, with some weighing as little as $1.1 trillion. Although these were indicative estimates rather than confirmed offering terms, the revisions highlighted growing caution toward expensive AI stocks.
Anthropic ultimately priced its IPO at $83.00 per share, implying an equity valuation of $1.5 trillion. By 20 Nov 2026, the shares were trading at around $97.17 (official closing price), 17% above the offer price. This gives traders a concrete starting point for assessing how much growth is already reflected in the valuation.
Newly listed stocks can experience sharp price movements, wider spreads, and liquidity fluctuations, making risk management particularly important. Exness‘ Negative Balance Protection provides an additional safeguard by resetting a negative trading account balance to zero following stop-outs, although it does not prevent trading losses.
Anthropic’s fundamentals remain impressive. Revenue surged over 1,200% YoY to $33.2 billion during the first nine months of 2026, while its operating loss narrowed to $1.3 billion. However, the company also disclosed approximately $895.4 billion in multiyear spending commitments, largely related to computing infrastructure, raising questions about future profitability and the capital required to sustain growth.
The broader market environment adds further uncertainty. The Democrats’ congressional sweep in November raised concerns over tighter AI regulation and potential restrictions on data-centre expansion, adding to uncertainty surrounding technology valuations. Meanwhile, persistent US inflation and a hawkish Federal Reserve have weighed on growth-stock valuations and financing conditions. Ongoing Middle East uncertainty also poses risks of renewed energy-driven inflation, potentially complicating the monetary policy outlook.
With multiple catalysts potentially driving ANT’s price movements, traders can use Exness Terminal to manage their exposure. The platform’s chart-based stop-loss orders and risk calculator can support position management, while one-click trading and bulk position closing provide additional flexibility during volatile market conditions. However, these tools cannot eliminate market risk or guarantee execution at a specified price.
Together, these developments raise a critical question: Can Anthropic’s extraordinary growth justify its market valuation when traders are less willing to pay a premium for future earnings? Continued Claude adoption, expanding enterprise demand, and improving profitability could support Anthropic’s share price.
However, a demanding valuation could leave little room for disappointment. Slower growth, rising computing costs, or renewed weakness across AI stocks may trigger selling pressure as the market reassesses the company’s prospects.
Anthropic’s Nasdaq debut marks a new chapter in the AI growth story, but its performance depends on whether the company can deliver on the expectations reflected in its share price. With ANT CFDs available at Exness, traders can position for either outcome while managing the risks associated with a newly listed company.







